Recall risk There have been multiple recall and contamination reports for Strides Pharma Inc. US liquids, including foreign substances and black particles in oral solutions, which highlights a need for enhanced quality assurance, stable formulations, and trusted supply to regain retailers’ and patients’ confidence.

Quality assurances Leverage the FDA Voluntary Action Indicated classification as a conversation starter with potential customers, emphasizing ongoing compliance improvements, robust QA processes, and proactive recalls management to position as a trusted supplier for sensitive liquid and oral medication categories.

Product breadth Strides US focuses on soft-gel capsules, oral solids, modified releases, topicals and liquids, offering a broad platform for contract manufacturing and private-label opportunities across generics, enabling cross-category win-backs and expanded SKU partnerships with distributors and retailers.

Sustainability angle Past investments in captive solar projects in India suggest a sustainability orientation; propose sustainability-aligned packaging, green manufacturing narratives, and energy-efficient processes as differentiators when engaging with eco-conscious healthcare buyers and insurers.

Strategic partnerships Recent collaborations and industry recognition imply openness to partnerships; target alliances with logistics providers, pharmacies, and healthcare training platforms to co-promote products, improve launch timelines, and expand market reach in US generics.